Elias Bechara

Title: Elias Bechara: Innovator in Antisense Oligonucleotides

Introduction

Elias Bechara is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of molecular biology, particularly through his innovative work on antisense oligonucleotides. His research focuses on the regulation of gene splicing, which has important implications for treating various diseases.

Latest Patents

Elias Bechara holds a patent for "Antisense oligonucleotides and uses thereof." This patent discloses novel compounds that comprise antisense oligonucleotides designed to regulate the splicing of the NUMB gene. Specifically, the invention provides an antisense oligonucleotide that reduces the inclusion of NUMB exon 9 in mature NUMB transcripts. The oligonucleotide consists of a sequence of at least 7 nucleotides that is complementary to a target region within exon 9 of a NUMB transcript. Additionally, the patent describes pharmaceutical compositions that include the antisense oligonucleotide and methods for treating proliferative diseases using these compounds.

Career Highlights

Throughout his career, Elias Bechara has worked with esteemed organizations such as the Institució Catalana de Recerca i Estudis Avançats and the Fundació Centre de Regulació Genòmica. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Elias has collaborated with notable colleagues, including Jordi Hernández Ribera and Juan Alberto Valcárcel Juárez. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Elias Bechara is a pioneering inventor whose work on antisense oligonucleotides has the potential to revolutionize treatments for proliferative diseases. His contributions to molecular biology continue to inspire future research and innovation in the field.